天津红日药业股份有限公司成立于1996年，于2000年进行股份制改造，2009年10月作为国内首批、天津首家企业在深证证券交易所创业板挂牌上市。（股票代码300026）。
公司自上市后连续荣登《福布斯》中国潜力企业榜、2013年度上市公司金牛奖百强综合榜，荣获2013年度金牛*佳创业成长公司、*具投资价值上市公司、中国*具竞争力医药上市公司20强、2013中国创业板上市公司十佳管理团队等殊荣。
产品包括：现代中药血必净注射液，盐酸法舒地尔口服制剂以及 抗肿瘤类、免疫调节类、血液类、神经类、麻醉类、呼吸类、血管类等原料药和中间体；
Tianjin Chase Sun Pharmaceutical Co. Ltd was founded in 1996 and the joint-stock transformation was completed in 2000. In 2009, Chase Sun pharmaceutical was listed on the Shenzhen Stock Exchange and became the first group of national GEM listed companies, also called as the first of Tianjin. （Stock code: 300026）
In 2013, the company won top 100 comprehensive list of listing Corporation, the best venture growing company in Gold Bull Award 2013, the most investment value listed Company, top 20 of the most competitive pharmaceutical listed Company in China, and the top 10 management team award of 2013 Chinese GEM Listing Corporation.
Products: Xuebijing Injection (Modern Traditonal Chinese Medicine), Fasudil hydrochloride oral preparation; and anti-tumor, immunoregulation, Cardiovascular and cerebrovascular, Anaesthesia API and intermediates;
红日药业技术转让中心占地2.5万平米，总投资3亿元，拥有多糖、多肽、抗肿瘤等多条合成药物生产线及大容量注射剂、小容量注射剂、冻干粉针及固体口服制剂生产线，完全按照2010版GMP要求建设，并拥有完善的检验分析实验室，有着完善的生产质控体系。技术转让中心致力于为客户提供从化学原料药及中间体的临床前期工艺开发直至工业化工艺优化的服务。
Technology transfer center of Chase Sun Pharma covers an area of 25,000 square meters with a total investment of 300 million Yuan. Technology transfer center possesses production lines for synthetic drugs, such a polusaccharide, peptides, anti-cancer drugs and production lines for large volume injection, small volume injection, freeze-dried powder and oral solid preparation. Each line is constructed in accordance with the GMP Standard (2010 revision) and has a laboratory for comprehensive testing and analysis with a complete production quality control system. Technology transfer center is committed to providing the customers services of process development of APIs and the intermediates from pre-clinical to the industrialization.
提供如下服务 （产品指原料药、中间体、精细化工品）：
Services (Product means API, intermediate and fine chemical)
1： 自产产品的生产销售 （GMP & Non GMP）；
Own product production, sales;
2： 产品合同定制加工 （GMP & Non GMP）；
Product Contract Manufacturing;
3： 产品研究、开发，成果转化，包括新剂型、新产品中试、放大研究；
Product research and development, achievements transformation including pilot studies and scale-up trials for new preparation and new products;
4： 产品生产工艺条件过程控制研究；
Studies of controlling the conditions and process of production;
5: 验证技术成熟型研究；
Validation of the maturity of the technical;
6： 临床试验用药和小批量产品生产；
Providing drugs for clinical trials and small batch production;
7： 技术研究、试验项目和科技项目的咨询与服务；
Technology research, pilot project and technology programs advising and services;
8： 药品注册咨询与服务；
Drug registration advising and services; |
